AMRUTANJANNSEAmrutanjan Health Care Limited· PharmaceuticalsLowNeutral
Announced Tue, 23 Sept · 17:14 IST

Amrutanjan Health Care Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 23, 2025

Board & Shareholder Meetings View source PDF

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Amrutanjan Health Care held its 88th AGM on September 23, 2025 via video conferencing, chaired by Managing Director S. Sambhu Prasad. A total of 84 shareholders participated, with 18 raising questions and suggestions during the meeting. The Chairman gave a presentation covering the company's history, key business highlights, power brands, modern trade performance, shareholder returns, financial summary, key metrics, and new products. Six ordinary resolutions were put to shareholder vote: adoption of FY25 audited financial statements, declaration of a final dividend of Rs. 2.60 per equity share (face value Re. 1), decision not to fill the board vacancy from retiring director Mr. Raghavan Govindan, approval of cost auditor remuneration, appointment of SPNP & Associates as secretarial auditor for a five-year term, and approval of non-executive director remuneration. The meeting concluded at 11:48 AM and voting results are to be declared within 48 hours.

Likely market impact

This is a routine AGM outcome filing with no contentious items; the Rs. 2.60 per share final dividend confirms shareholder returns for FY25. The non-replacement of a retiring director and the long-term secretarial auditor appointment signal board continuity. Investors should monitor the upcoming voting results and the chairman's performance presentation for signals on FY26 outlook.